These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10208099)

  • 1. [New antithrombotic drugs].
    Taliani MR; Agnelli G
    Recenti Prog Med; 1999 Feb; 90(2):86-93. PubMed ID: 10208099
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance.
    Verstraete M
    Thromb Haemost; 1997 Jul; 78(1):357-63. PubMed ID: 9198179
    [No Abstract]   [Full Text] [Related]  

  • 4. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in PCI: why not heparin?
    Shahzad A; Cooper RM; Stables RH
    EuroIntervention; 2013 Aug; 9(4):423-6. PubMed ID: 23965346
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
    Kleiman NS
    Coron Artery Dis; 1996 Jul; 7(7):508-15. PubMed ID: 8913678
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
    White HD
    Am Heart J; 2002 Feb; 143(2):189-92. PubMed ID: 11835018
    [No Abstract]   [Full Text] [Related]  

  • 9. Failed thrombolysis in myocardial infarction.
    Qasim A; Chauhan A; More RS
    Int J Cardiol; 2000 Aug; 75(1):5-14. PubMed ID: 11054500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?
    Di Sciascio G; Mangiacapra F
    J Am Coll Cardiol; 2012 Jul; 60(5):378-80. PubMed ID: 22682552
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
    Bassand JP
    Haemostasis; 2000; 30 Suppl 2():114-21; discussion 106-7. PubMed ID: 11251354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin in acute myocardial infarction: "primum non nocere": the eternal dilemma: balancing risks and benefits in high-risk patients.
    Alfonso F; Paulo M
    JACC Cardiovasc Interv; 2010 Aug; 3(8):803-5. PubMed ID: 20723850
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials of direct thrombin inhibitors during invasive procedures.
    Hermann JP; Kutryk MJ; Serruys PW
    Thromb Haemost; 1997 Jul; 78(1):367-76. PubMed ID: 9198181
    [No Abstract]   [Full Text] [Related]  

  • 14. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
    French MH; Faxon DP
    Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of differing pharmacologic strategies on infarct size in primary PCI--more confirmatory data for bivalirudin.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1090-1. PubMed ID: 22674760
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular drugs in the new millennium.
    Frangos SG; Chen AH; Sumpio B
    J Am Coll Surg; 2000 Jul; 191(1):76-92. PubMed ID: 10898187
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulant therapy in unstable angina.
    Choy JB; Armstrong PW
    Cardiol Clin; 1999 May; 17(2):327-43, ix. PubMed ID: 10384830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct thrombin antagonists].
    Lankes W; Fleischer K; Gulba DC
    Herz; 2001 Apr; 26 Suppl 1():46-52. PubMed ID: 11349627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition.
    Reginelli JP; Chew D
    J Interv Cardiol; 2002 Apr; 15(2):141-6. PubMed ID: 12063809
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.